ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207 | -45.7% | 10,307 | -23.6% | 0.02% | -46.7% |
| Q2 2023 | $381 | +87.7% | 13,492 | +14.1% | 0.03% | +100.0% |
| Q1 2023 | $203 | -16.1% | 11,821 | -1.6% | 0.02% | -25.0% |
| Q4 2022 | $242 | -99.9% | 12,016 | -4.8% | 0.02% | -23.1% |
| Q3 2022 | $274,000 | -32.0% | 12,628 | -12.0% | 0.03% | -29.7% |
| Q2 2022 | $403,000 | +43.9% | 14,356 | +136.2% | 0.04% | +311.1% |
| Q1 2022 | $280,000 | – | 6,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |